| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Articles |
-Glucosidase Activity in Blood Spots as a Diagnostic Test for Pompe Disease
1 Lysosomal Diseases Research Unit, Department of Chemical Pathology, Women’s and Children’s Hospital, 72 King William Rd., North Adelaide, South Australia 5006, Australia.
aAuthor for correspondence. Fax 61-8-8204-7100; e-mail peter.meikle{at}adelaide.edu.au.
Background: Pompe disease is an autosomal recessive disorder of glycogen metabolism that is characterized by a deficiency of the lysosomal acid 
-glucosidase. Enzyme replacement therapy for the infantile and juvenile forms of Pompe disease currently is undergoing clinical trials. Early diagnosis before the onset of irreversible pathology is thought to be critical for maximum efficacy of current and proposed therapies. In the absence of a family history, the presymptomatic detection of these disorders ideally can be achieved through a newborn-screening program. Currently, the clinical diagnosis of Pompe disease is confirmed by the virtual absence, in infantile onset, or a marked reduction, in juvenile and adult onset, of acid -glucosidase activity in muscle biopsies and cultured fibroblasts. These assays are invasive and not suited to large-scale screening.
Methods: A sensitive immune-capture enzyme activity assay for the measurement of acid -glucosidase protein was developed and used to determine the activity of this enzyme in dried-blood spots from newborn and adult controls, Pompe-affected individuals, and obligate heterozygotes.
Results: Pompe-affected individuals showed an almost total absence of acid -glucosidase activity in blood spots. The assay showed a sensitivity and specificity of 100% for the identification of Pompe-affected individuals.
Conclusions: The determination of acid -glucosidase activity in dried-blood spots is a useful, noninvasive diagnostic assay for the identification of Pompe disease. With further validation, this procedure could be adapted for use with blood spots collected in newborn-screening programs.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  Mohd. A. F. Tan, C. J. Dean, J. J. Hopwood, and P. J. Meikle Diagnosis of Metachromatic Leukodystrophy by Immune Quantification of Arylsulphatase A Protein and Activity in Dried Blood Spots Clin. Chem., November 1, 2008; 54(11): 1925 - 1927. [Full Text] [PDF]
|
|
|
|
|
|
E. Parkinson-Lawrence, M. Fuller, J. J. Hopwood, P. J. Meikle, and D. A. Brooks Immunochemistry of Lysosomal Storage Disorders Clin. Chem., September 1, 2006; 52(9): 1660 - 1668. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Dean, M. R. Bockmann, J. J. Hopwood, D. A. Brooks, and P. J. Meikle Detection of Mucopolysaccharidosis Type II by Measurement of Iduronate-2-Sulfatase in Dried Blood Spots and Plasma Samples Clin. Chem., April 1, 2006; 52(4): 643 - 649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Millington Newborn Screening for Lysosomal Storage Disorders Clin. Chem., May 1, 2005; 51(5): 808 - 809. [Full Text] [PDF]
|
|
|
|
|
|
D. Wang, B. Eadala, M. Sadilek, N. A. Chamoles, F. Turecek, C. R. Scott, and M. H. Gelb Tandem Mass Spectrometric Analysis of Dried Blood Spots for Screening of Mucopolysaccharidosis I in Newborns Clin. Chem., May 1, 2005; 51(5): 898 - 900. [Full Text] [PDF]
|
|
|
|
|
|
M. Fuller, M. Lovejoy, D. A. Brooks, M. L. Harkin, J. J. Hopwood, and P. J. Meikle Immunoquantification of {alpha}-Galactosidase: Evaluation for the Diagnosis of Fabry Disease Clin. Chem., November 1, 2004; 50(11): 1979 - 1985. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Meikle, E. Ranieri, H. Simonsen, T. Rozaklis, S. L. Ramsay, P. D. Whitfield, M. Fuller, E. Christensen, F. Skovby, and J. J. Hopwood Newborn Screening for Lysosomal Storage Disorders: Clinical Evaluation of a Two-Tier Strategy Pediatrics, October 1, 2004; 114(4): 909 - 916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Li, C. R. Scott, N. A. Chamoles, A. Ghavami, B. M. Pinto, F. Turecek, and M. H. Gelb Direct Multiplex Assay of Lysosomal Enzymes in Dried Blood Spots for Newborn Screening Clin. Chem., October 1, 2004; 50(10): 1785 - 1796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Li, K. Brockmann, F. Turecek, C. R. Scott, and M. H. Gelb Tandem Mass Spectrometry for the Direct Assay of Enzymes in Dried Blood Spots: Application to Newborn Screening for Krabbe Disease Clin. Chem., March 1, 2004; 50(3): 638 - 640. [Full Text] [PDF]
|
|
|
|
|
|
B. Lumbreras-Lacarra, J. M. Ramos-Rincon, and I. Hernandez-Aguado Methodology in Diagnostic Laboratory Test Research in Clinical Chemistry and Clinical Chemistry and Laboratory Medicine Clin. Chem., March 1, 2004; 50(3): 530 - 536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. W. Lam, Y. P. Yuen, K. Y. Chan, S. F. Tong, C. K. Lai, T. C. Chow, K. C. Lee, Y. W. Chan, and F. Martiniuk Juvenile-onset glycogen storage disease type II with novel mutations in acid {alpha}-glucosidase gene Neurology, February 25, 2003; 60(4): 715 - 717. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Yan, N. Raben, and P. Plotz The Human Acid alpha -Glucosidase Gene Is a Novel Target of the Notch-1/Hes-1 Signaling Pathway J. Biol. Chem., August 9, 2002; 277(33): 29760 - 29764. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Rozaklis, S. L. Ramsay, P. D. Whitfield, E. Ranieri, J. J. Hopwood, and P. J. Meikle Determination of Oligosaccharides in Pompe Disease by Electrospray Ionization Tandem Mass Spectrometry Clin. Chem., January 1, 2002; 48(1): 131 - 139. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
